Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy release_24uwxh6fk5gddhgtnblqnxa3ta

by Kai Zhang, Qiongqiong Li, Yaru Zhang, Wenya Shang, Li Wei, Hongfen Li, Shan Gao, Tiekun Yan, Junya Jia, Youxia Liu, Shan Lin

Published in Kidney & Blood Pressure Research by S. Karger AG.

2019   Volume 44, Issue 5, p1-11

Abstract

Aberrant galactose-deficient IgA1 molecules (Gd-IgA1) are important causal factors in IgA nephropathy (IgAN); however, the detection of Gd-IgA1 in IgAN is complicated and instable. A monoclonal antibody, KM55, which specifically recognizes Gd-IgA1 has been developed. In the present study, we further explored the clinical significance of Gd-IgA1 using KM55. In this study, we enrolled 75 patients with IgAN and 80 healthy controls and detected the plasma Gd-IgA1 levels using the KM55 ELISA method. We also stained -mesangial Gd-IgA1 deposition using KM55. We observed that the levels of plasma Gd-IgA1 in IgAN patients were elevated compared to the corresponding levels of healthy controls. Patients were divided into 2 groups based on the median of Gd-IgA1. Patients with high Gd-IgA1 levels had significantly higher levels of uric acid (UA) and IgA. The other clinical manifestations demonstrated that there were no differences in age, sex, blood pressure, initial proteinuria, hematuria, estimated glomerular filtration rate and Oxford pathological classification between the 2 groups of patients. In addition, positive correlations were observed between Gd-IgA1 and Bb, C3a, C4d and MAC. Mesangial Gd-IgA1 was positive in IgAN but negative in the normal renal tissue adjacent to neoplasm. We next analyzed the correlation between plasma Gd-IgA1 and mesangial Gd-IgA1 deposition. The results showed that a high level of plasma Gd-IgA1 was related to the deposition of mesangial Gd-IgA1, although the difference was not significant. We verified the elevated level of plasma and -mesangial Gd-IgA1 in patients with IgAN by KM55, which provided an alternative, easy, and reliable tool for diagnosis and activity assessment of IgAN. The level of plasma Gd-IgA1 positively correlated with levels of UA, total IgA levels, and complement activation products.
In text/plain format

Archived Files and Locations

application/pdf   1.1 MB
file_kaic33xjsvb23hrun6o36mjbwi
www.karger.com (publisher)
web.archive.org (webarchive)
application/pdf   1.0 MB
file_nejh6m6okffgrcza6j3afczdly

Web Captures

https://www.karger.com/Article/FullText/502579
2020-09-08 22:50:54 | 46 resources
webcapture_fbk5h3fc3rdsjdgzjtonve4nhq
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2019-10-01
Language   en ?
DOI  10.1159/000502579
PubMed  31574506
Container Metadata
Open Access Publication
In DOAJ
In Keepers Registry
ISSN-L:  1420-4096
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 08402296-4648-47ce-96c5-d032850eb12e
API URL: JSON